Clinical trial Recruiting at 1 site Interventional Ages 40 to 70

Comparison of two TLIF procedures for single-level lumbar spinal stenosis

Official title: Comparative Analysis of L-Unitary Soft Endoscope Transforaminal Lumbar Interbody Fusion (LUSE-TLIF) Versus Minimally Invasive Transforaminal Lumbar Interbody Fusion (MIS-TLIF) in the Treatment of Single-Level Lumbar Spinal Stenosis (LSS): A Single-Center, Prospective, Randomized Controlled Trial

Run by The Third Affiliated Hospital of Southern Medical University · NCT07588555 · Data updated 2026-11-12

This trial tests two minimally invasive TLIF procedures (LUSE-TLIF and MIS-TLIF) to see which better helps people with single-level lumbar spinal stenosis who have not improved with non-surgical treatments.

Quick facts

Study typeInterventional
Ages40 Years to 70 Years
SexAll
Enrollment276 (estimated)
SponsorThe Third Affiliated Hospital of Southern Medical University
Government
Locations1 site (Guangzhou, Guangdong)
StatusRecruiting
StartedMarch 18, 2026
Main results expectedDecember 31, 2031
Study endsDecember 31, 2031
Registry record updatedMay 14, 2026
Trial IDNCT07588555 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 40–70 with single-level lumbar spinal stenosis and grade II or higher spondylolisthesis or lumbar instability, who have not improved with at least 3 months of non-surgical treatment and are suitable for TLIF.

Probably not a fit

Patients without single-level stenosis, with previous lumbar spine surgery, or with exclusionary conditions may not benefit from these TLIF approaches.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, randomized study conducted at a single center to compare two TLIF techniques for treating single-level lumbar spinal stenosis with accompanying instability or spondylolisthesis. Participants aged 40–70 who have persistent leg and/or back pain despite non-surgical care are randomized to receive either LUSE-TLIF or MIS-TLIF. Outcomes focus on safety, fusion success, pain relief, function, and recovery, using standard postoperative assessments over a defined follow-up period. The study aims to determine whether the minimally invasive approach offers advantages in reducing tissue trauma and improving outcomes compared with the alternative TLIF method. Recruitment is limited to patients meeting specific imaging and clinical criteria and who provide informed consent at the enrolling center.

Why it matters

Potential benefit: If successful, the trial could identify a preferred TLIF technique that provides better pain relief, function, and recovery for patients with single-level LSS.

How similar studies have gone: Previous studies of TLIF approaches have shown comparable safety and varying degrees of benefits; this study builds on that by directly comparing two minimally invasive techniques.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ranging from 40 to 70 years, irrespective of sex.
* Presence of bilateral lower-limb pain and neurogenic claudication, with or without low back pain.
* Preoperative computed tomography or magnetic resonance imaging confirming single-level lumbar spinal stenosis accompanied by grade II or higher lumbar spondylolisthesis and/or lumbar instability.
* Persistent pain within 7 days prior to enrollment, with inadequate response to nonsurgical treatment for more than 3 months.
* Willingness to provide written informed consent and ability to comply with the study protocol and visit schedule.

Exclusion Criteria:

* Patients with evidence of vascular claudication identified by lower-limb color Doppler ultrasound.
* Patients with a history of previous lumbar spine surgery.
* Coexistence of severe lumbar disc herniation, spinal deformity, spinal tumor, infection, or inflammatory diseases.
* Pregnancy or lactation.
* Presence of severe underlying medical conditions or psychiatric disorders that preclude tolerance of the procedure.
* Known concurrent diseases considered by the investigator to preclude study entry.
* Inability to comply with study assessments or complete questionnaires for any reason.
* Patients deemed unsuitable for participation in this trial as judged by the investigator.

Where it's running

  • The Third Affiliated Hospital of Southern Medical University
    Guangzhou, Guangdong, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.